OPTEC International Inc (OTCMKTS:OPTI) Expects To Sell Antigen Kits Within The Week.

Yesterday OPTEC International Inc (OTCMKTS:OPTI) announced they received their first shipment of home use FDA-approved rapid antigen test kits at its OPTEC Vista distribution center in California.

Fridays Market Action
OPTEC International Inc (OTCMKTS:OPTI) is off slightly in Fridays mornings session. As of 10:15 shares are trading down 5% to .1235 off .0075. Volume is light with just under 3 million shares trading hands. Potential pivot points to keep an eye on are .1339 and .1425 above and .1282 and .1197 below.  

OPTEC CEO Roger Pawson stated “We are fortunate to have received some of the first FDA authorized 15 Minute Home Use Test kits for consumer and business rapid testing with onsite results in 15 minutes or less. We are anticipating having the kits available for order by consumers on the company’s website within the next week.”

OPTI will be offering both versions of the Antigen 10 Minute Nasal Rapid Test Kits: online, via distributors, media channels, and bulk PPE networks.

About OPTEC International, Inc. With Locations in Carlsbad and Vista, California, OPTEC International is a developer and manufacturer of electronic LED, Ultraviolet (UV) & UV-C safety products and related advanced technologies and PPE (Personal Protection Equipment) products. The company’s Safe-Scan product line is being launched at a time when HR directors and facilities managers are experiencing extreme concern with respect to keeping environments safe during the global pandemic crisis and the safe reopening of the U.S. economy.

OPTEC International Inc (OTCMKTS:OPTI) has attracted some interest from investors recently due to their UV and UV safety products and now may be a viable coronavirus play.

Related Posts

About The Author

Add Comment